SOLICITATION NOTICE
B -- Analyses of data collected from the Prostate Cancer Therapy Selection Study (PCATS)
- Notice Date
- 8/28/2009
- Notice Type
- Presolicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-90220-AV
- Archive Date
- 9/22/2009
- Point of Contact
- Ashley L. Virts,
- E-Mail Address
-
virtsa@mail.nih.gov
(virtsa@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS), Outcomes Research Branch (ORB), plans to procure on a sole source basis analyses of data collected from the Prostate Cancer Therapy Selection Study (PCATS) from Fred Hutchinson Cancer Research Center, PO. Box 19024, 1100 Fairview Avenue, N., J6-500, Seattle, WA 98109. The services herein are being procured in accordance with the simplified acquisition procedures authorized by FAR Part 13. The North American Industry Classification System Code is 541690 and the business size standard is $7 M. The period of performance shall be twelve (12) months from date of award. Relatively little is known about US prostate cancer patients' use of complementary and alternative medicine (CAM) as an adjunct to traditional treatments. Moreover, most surveys of CAM use among prostate cancer survivors have surveyed patients for months to years after they were diagnosed and embarked on a treatment program. This presents difficulties in understanding factors that were present at the time of diagnosis that might predict patterns of CAM use following diagnosis, particularly issues such as cancer fear and control issues and trust in the health care system, which may be influenced by patients' experiences with prostate cancer treatment. In addition, no study of prostate cancer patients has evaluated the relationship between the sources patients use to gather information about treatment options, particularly the Internet, and CAM use. The purpose of this project is to conduct analyses of the data collected through the collaborative study entitled, Treatment Choice and Quality of Life for Men with Localized Prostate Cancer. This project is also known by its working title, the Prostate Cancer Therapy Selection Study (PCATS) and was initially funded by NCI as a Rapid Response Surveillance Study to be conducted by multiple SEER registries. The objective of the PCATS study was to recruit men newly diagnosed with prostate cancer prior to initiating treatment, in order to prospectively evaluate the treatment decision-making process. A total of 804 eligible participants completed baseline surveys at the time of diagnosis. The majority of patients, 560 (70%), returned the survey before treatment and, of those, 512 (91%) also completed the 6 month follow-up survey. As part of this contract, the contractor shall analyze data from the PCATS study and produce two research manuscripts: Manuscript 1: Pre-treatment factors associated with CAM use following treatment among local stage prostate cancer patients: A multi-site study, and Manuscript 2: CAM use, side effects, and treatment satisfaction among men with local stage prostate cancer. The proposed contractor, Fred Hutchinson Cancer Research Center (FHCRC) is uniquely qualified to conduct the analyses of the PCATS study data. The idea for the PCATS study was originally proposed as a SEER study to NCI by the proposed contractor, FHCRC. Dr. Scott Ramsey and his research team at FHCRC led the study design, development of patient surveys, data collection, and analyses on the initial contract for the PCATS study funded by NCI. Thus, FHCRC holds proprietary data regarding the PCATS study and the associated datasets. Dr. Ramsey's research group at FHCRC have a unique blend of experience and expertise in prostate cancer, quality of care, and survey methods and analyses that are critical to the objectives outlined in this procurement. In addition to having led the PCATS study, the FHCRC, under the leadership of Dr. Ramsey and his research team, has published a number of studies on the cost effectiveness of screening and treatment for prostate cancer, the short- and long-term direct medical costs of cancer, willingness to pay for antihypertensive therapy, and quality of life studies of persons with colorectal cancer. Dr. Ramsey's research group at FHCRC is also a participant in the NCI-funded Cancer Care Outcomes Research & Surveillance Consortium (CanCORS), a multi-center study of the quality of cancer care in the United States. More specific to this project, FHCRC also serves as the coordinating center for the CDC-funded Special Interest Study, "Localized Prostate Cancer: Decision Making and Outcomes." The research group at FHCRC has vast experience in survey and database design, survey administration and data collection, data preparation, and data analysis and they are intimately familiar with the data collected from the novel PCATS prostate study and have led the data analyses and publication efforts among the PCATS investigators. In addition, the FHCRC holds proprietary data relating to the work outlined in this procurement; accordingly, they are uniquely qualified to perform the work under this contract. This is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the NCI to determine if the party can meet this requirement. One (1) original and one (1) copy of the capability statement must be received in the contracting office by 11:00 a.m. ET on September 7, 2009. All questions must be in writing and can be faxed to 301-402-4513 or sent via email to Ashley Virts at virtsa@mail.nih.gov. It is the vendor's responsibility to ensure questions have been received. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractor must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Application (ORCA). Please reference NCI-90220-AV on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/NCI-90220-AV/listing.html)
- Record
- SN01932065-W 20090830/090829004737-ac70c6e4a4cf9ea4c5006d7f764b1cad (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |